Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells

组蛋白甲基转移酶DOT1L维持细胞状态并限制CD8 T细胞的细胞毒性潜能。

阅读:6
作者:Muddassir Malik ,Willem-Jan de Leeuw ,Muhammad Assad Aslam ,Eliza Mari Kwesi-Maliepaard ,Teun van den Brand ,Bram van den Broek ,Maxime Kempers ,Liesbeth Hoekman ,Natalie Proost ,Tibor van Welsem ,Nikolina Bąbała ,Elselien Frijlink ,Elzo de Wit ,Jannie Borst ,Heinz Jacobs ,Fred van Leeuwen

Abstract

The histone methyltransferase DOT1L is emerging as a central epigenetic regulator in immune cells. Loss of DOT1L during development of CD8 T cells in vivo leads to gain of memory characteristics but has also been reported to compromise CD8 T cell viability and antitumor reactivity. Here, we determined the cell-intrinsic role of DOT1L in mature mouse CD8 T cells. After conditional deletion of Dot1L in vitro, CD8 T cells retained in vivo proliferative capacity and antitumor reactivity. Moreover, Dot1L knockout CD8 T cells showed increased antigen-specific cytotoxicity toward tumor cells in vitro. Mechanistically, loss of DOT1L resulted in an altered cell state with loss of T cell and gain of innate-like features. These transcriptional changes were mediated by loss of DOT1L methyltransferase activity in a dose-dependent manner. Our findings show that in mature CD8 T cells, ablation of DOT1L activity is well tolerated and reprograms them to gain innate-like memory cell characteristics and enhance intrinsic cytotoxic capacity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。